Literature DB >> 26456750

Novel delivery approaches for cancer therapeutics.

Ashim K Mitra1, Vibhuti Agrahari2, Abhirup Mandal2, Kishore Cholkar3, Chandramouli Natarajan2, Sujay Shah2, Mary Joseph2, Hoang M Trinh2, Ravi Vaishya4, Xiaoyan Yang2, Yi Hao2, Varun Khurana5, Dhananjay Pal2.   

Abstract

Currently, a majority of cancer treatment strategies are based on the removal of tumor mass mainly by surgery. Chemical and physical treatments such as chemo- and radiotherapies have also made a major contribution in inhibiting rapid growth of malignant cells. Furthermore, these approaches are often combined to enhance therapeutic indices. It is widely known that surgery, chemo- and radiotherapy also inhibit normal cells growth. In addition, these treatment modalities are associated with severe side effects and high toxicity which in turn lead to low quality of life. This review encompasses novel strategies for more effective chemotherapeutic delivery aiming to generate better prognosis. Currently, cancer treatment is a highly dynamic field and significant advances are being made in the development of novel cancer treatment strategies. In contrast to conventional cancer therapeutics, novel approaches such as ligand or receptor based targeting, triggered release, intracellular drug targeting, gene delivery, cancer stem cell therapy, magnetic drug targeting and ultrasound-mediated drug delivery, have added new modalities for cancer treatment. These approaches have led to selective detection of malignant cells leading to their eradication with minimal side effects. Lowering multi-drug resistance and involving influx transportation in targeted drug delivery to cancer cells can also contribute significantly in the therapeutic interventions in cancer.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Cell Penetrating Peptides; Chemotherapeutics; Efflux Pumps; Gene therapy; Immunotherapy; Stem cells; Targeted Drug Delivery; Tumor

Mesh:

Substances:

Year:  2015        PMID: 26456750      PMCID: PMC4656058          DOI: 10.1016/j.jconrel.2015.09.067

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  353 in total

Review 1.  Transformation-induced mutations in transgenic plants: analysis and biosafety implications.

Authors:  Allison K Wilson; Jonathan R Latham; Ricarda A Steinbrecher
Journal:  Biotechnol Genet Eng Rev       Date:  2006

2.  LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases.

Authors:  Carola Leuschner; Challa S S R Kumar; William Hansel; Wole Soboyejo; Jikou Zhou; Josef Hormes
Journal:  Breast Cancer Res Treat       Date:  2006-06-03       Impact factor: 4.872

3.  Multifunctional magnetic nanoparticles modified with polyethylenimine and folic acid for biomedical theranostics.

Authors:  Hyunhee Yoo; Seung-Kwan Moon; Taewon Hwang; Yong Seok Kim; Joo-Hwan Kim; Sung-Wook Choi; Jung Hyun Kim
Journal:  Langmuir       Date:  2013-05-07       Impact factor: 3.882

4.  Gene electrotransfer clinical trials.

Authors:  Richard Heller; Loree C Heller
Journal:  Adv Genet       Date:  2014-12-04       Impact factor: 1.944

Review 5.  Orchestrating immune check-point blockade for cancer immunotherapy in combinations.

Authors:  Jose Luis Perez-Gracia; Sara Labiano; Maria E Rodriguez-Ruiz; Miguel F Sanmamed; Ignacio Melero
Journal:  Curr Opin Immunol       Date:  2014-01-28       Impact factor: 7.486

6.  Novel cleavable cell-penetrating peptide-drug conjugates: synthesis and characterization.

Authors:  Marco Lelle; Stefanie U Frick; Kerstin Steinbrink; Kalina Peneva
Journal:  J Pept Sci       Date:  2014-02-19       Impact factor: 1.905

7.  Aptamer-conjugated Mn3O4@SiO2 core-shell nanoprobes for targeted magnetic resonance imaging.

Authors:  He Hu; Antao Dai; Jin Sun; Xiangyuan Li; Fenghou Gao; Lizhong Wu; Yong Fang; Hong Yang; Lu An; Huixia Wu; Shiping Yang
Journal:  Nanoscale       Date:  2013-09-13       Impact factor: 7.790

8.  CO2 gas induced drug release from pH-sensitive liposome to circumvent doxorubicin resistant cells.

Authors:  Juan Liu; Huili Ma; Tuo Wei; Xing-Jie Liang
Journal:  Chem Commun (Camb)       Date:  2012-04-12       Impact factor: 6.222

9.  Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation.

Authors:  Bernadet D M Meijering; Lynda J M Juffermans; Annemieke van Wamel; Rob H Henning; Inge S Zuhorn; Marcia Emmer; Amanda M G Versteilen; Walter J Paulus; Wiek H van Gilst; Klazina Kooiman; Nico de Jong; René J P Musters; Leo E Deelman; Otto Kamp
Journal:  Circ Res       Date:  2009-01-22       Impact factor: 17.367

10.  Recombinant adeno-associated virus encoding Epstein-Barr virus latent membrane proteins fused with heat shock protein as a potential vaccine for nasopharyngeal carcinoma.

Authors:  Jianqing Pan; Qin Zhang; Jianfeng Zhou; Ding Ma; Xiao Xiao; Dao Wen Wang
Journal:  Mol Cancer Ther       Date:  2009-09-01       Impact factor: 6.261

View more
  31 in total

Review 1.  Tumor-associated macrophages: Role in the pathological process of tumorigenesis and prospective therapeutic use (Review).

Authors:  Olga V Zhukova; Tatiana F Kovaleva; Evgenia V Arkhipova; Sergey A Ryabov; Irina V Mukhina
Journal:  Biomed Rep       Date:  2020-08-28

Review 2.  The potential for tumor suppressor gene therapy in head and neck cancer.

Authors:  Andrew C Birkeland; Megan L Ludwig; Matthew E Spector; J Chad Brenner
Journal:  Discov Med       Date:  2016-01       Impact factor: 2.970

Review 3.  Tumor progression: the neuronal input.

Authors:  Marco Arese; Federico Bussolino; Margherita Pergolizzi; Laura Bizzozero; Davide Pascal
Journal:  Ann Transl Med       Date:  2018-03

4.  Bone-targeting nanoparticle to co-deliver decitabine and arsenic trioxide for effective therapy of myelodysplastic syndrome with low systemic toxicity.

Authors:  Xiaoyan Wu; Zhenhua Hu; Sara Nizzero; Guodong Zhang; Maricela R Ramirez; Ce Shi; Jin Zhou; Mauro Ferrari; Haifa Shen
Journal:  J Control Release       Date:  2017-10-16       Impact factor: 9.776

5.  Metal-Organic Polyhedron Capped with Cucurbit[8]uril Delivers Doxorubicin to Cancer Cells.

Authors:  Soumen K Samanta; Damien Moncelet; Volker Briken; Lyle Isaacs
Journal:  J Am Chem Soc       Date:  2016-10-20       Impact factor: 15.419

6.  Preparation and Characterization of Dentin Phosphophoryn-Derived Peptide-Functionalized Lignin Nanoparticles for Enhanced Cellular Uptake.

Authors:  Patrícia Figueiredo; Mika H Sipponen; Kalle Lintinen; Alexandra Correia; Alexandros Kiriazis; Jari Yli-Kauhaluoma; Monika Österberg; Anne George; Jouni Hirvonen; Mauri A Kostiainen; Hélder A Santos
Journal:  Small       Date:  2019-05-06       Impact factor: 13.281

Review 7.  Advances in Delivery of Chemotherapeutic Agents for Cancer Treatment.

Authors:  Asmita Yadav; Sakshi Singh; Harmik Sohi; Shweta Dang
Journal:  AAPS PharmSciTech       Date:  2021-12-14       Impact factor: 3.246

Review 8.  Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.

Authors:  Jianing Meng; Vivek Agrahari; Ibrahima Youm
Journal:  J Neuroimmune Pharmacol       Date:  2016-07-23       Impact factor: 4.147

Review 9.  Peptide-Drug Conjugates with Different Linkers for Cancer Therapy.

Authors:  Mona Alas; Azam Saghaeidehkordi; Kamaljit Kaur
Journal:  J Med Chem       Date:  2020-12-31       Impact factor: 7.446

10.  Evaluation of a Keratin 1 Targeting Peptide-Doxorubicin Conjugate in a Mouse Model of Triple-Negative Breast Cancer.

Authors:  Azam Saghaeidehkordi; Shiuan Chen; Sun Yang; Kamaljit Kaur
Journal:  Pharmaceutics       Date:  2021-05-05       Impact factor: 6.525

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.